Brian Birk's most recent trade in Exagen Inc was a trade of 9,000 Stock Option(right to buy) done . Disclosure was reported to the exchange on June 9, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Exagen Inc | Brian Birk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 9,000 | 9,000 | - | - | Stock Option(right to buy) | |
Exagen Inc | Brian Birk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 9,000 | 9,000 | - | - | Stock Option(right to buy) | |
Exagen Inc | Brian Birk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 9,000 | 9,000 | - | - | Stock Option(right to buy) | |
Exagen Inc | Brian Birk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 9,000 | 9,000 | - | - | Stock Option(right to buy) |